BE1003021A3 - Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. - Google Patents

Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. Download PDF

Info

Publication number
BE1003021A3
BE1003021A3 BE8900321A BE8900321A BE1003021A3 BE 1003021 A3 BE1003021 A3 BE 1003021A3 BE 8900321 A BE8900321 A BE 8900321A BE 8900321 A BE8900321 A BE 8900321A BE 1003021 A3 BE1003021 A3 BE 1003021A3
Authority
BE
Belgium
Prior art keywords
cardiac
preparing
pharmaceutical compositions
cardiovascular system
same
Prior art date
Application number
BE8900321A
Other languages
English (en)
French (fr)
Inventor
Nagy Peter Literati
Hegedus Erzsebet Radvany
Maria Boros
Jeno Szilbereky
Gyoergy Blasko
Bela Gachalyi
Nemes Gizella Hamar
Gabor Nemeth
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Application granted granted Critical
Publication of BE1003021A3 publication Critical patent/BE1003021A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
BE8900321A 1988-03-23 1989-03-23 Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. BE1003021A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart

Publications (1)

Publication Number Publication Date
BE1003021A3 true BE1003021A3 (fr) 1991-10-29

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900321A BE1003021A3 (fr) 1988-03-23 1989-03-23 Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer.

Country Status (15)

Country Link
JP (1) JPH0222228A (enExample)
KR (1) KR890014104A (enExample)
BE (1) BE1003021A3 (enExample)
CA (1) CA1319607C (enExample)
CH (1) CH677732A5 (enExample)
DE (1) DE3909707A1 (enExample)
ES (1) ES2014060A6 (enExample)
FI (1) FI891438A7 (enExample)
FR (1) FR2628972B1 (enExample)
GB (1) GB2216421A (enExample)
HU (1) HU210122B (enExample)
IT (1) IT1229205B (enExample)
LU (1) LU87488A1 (enExample)
NL (1) NL8900742A (enExample)
SE (1) SE8901041L (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (ja) * 1990-11-06 2000-12-04 ソニー株式会社 電子機器
KR19990015198A (ko) * 1997-08-02 1999-03-05 손남율 식물성 항생제
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
BE1012495A3 (fr) 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
EP1501493B1 (en) * 2002-05-03 2009-10-07 Pronova BioPharma Norge AS Use of epa and dha in secondary prevention of strokes
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (fr) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition regeneratrice et regulatrice de l'appareil digestif
US20090232916A1 (en) * 2004-08-09 2009-09-17 Avidor Shulman Food products for diabetics
AU2005270831B2 (en) 2004-08-10 2011-08-25 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
EP2242489A1 (en) 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
RU2007143510A (ru) 2005-04-27 2009-06-10 Яллал МЕССАДЕК (BE) Инсулиновые композиции
ITMI20052483A1 (it) * 2005-12-23 2007-06-24 Novamont Spa Esche biodegradabili
FR2935394B1 (fr) 2008-08-29 2013-03-08 Eco Solution Microorganismes photosynthetiques enrichis en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie
FR2935393B1 (fr) 2008-08-29 2012-08-24 Tetrahedron Bacteries et levures enrichies en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2148713A (en) * 1983-10-24 1985-06-05 Century Lab Inc Pharmaceutical composition and food product comprising higher fatty acids
FR2612373A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions dietetiques et procede pour leur preparation
FR2612399A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation
GB2216418A (en) * 1988-03-09 1989-10-11 Biorex Kft Antiviral and immunostimulating compositions comprising amino acids and polyunsaturated higher fatty acids.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2148713A (en) * 1983-10-24 1985-06-05 Century Lab Inc Pharmaceutical composition and food product comprising higher fatty acids
FR2612373A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions dietetiques et procede pour leur preparation
FR2612399A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation
GB2216418A (en) * 1988-03-09 1989-10-11 Biorex Kft Antiviral and immunostimulating compositions comprising amino acids and polyunsaturated higher fatty acids.

Also Published As

Publication number Publication date
SE8901041D0 (sv) 1989-03-23
FI891438A0 (fi) 1989-03-23
FR2628972A1 (fr) 1989-09-29
GB2216421A (en) 1989-10-11
NL8900742A (nl) 1989-10-16
FI891438L (fi) 1989-09-24
HU210122B (en) 1995-02-28
KR890014104A (ko) 1989-10-21
HUT60436A (en) 1992-09-28
CH677732A5 (enExample) 1991-06-28
IT1229205B (it) 1991-07-25
LU87488A1 (fr) 1990-10-02
DE3909707A1 (de) 1989-10-05
FR2628972B1 (fr) 1994-09-23
SE8901041L (sv) 1989-09-24
CA1319607C (en) 1993-06-29
GB8906856D0 (en) 1989-05-10
JPH0222228A (ja) 1990-01-25
IT8919876A0 (it) 1989-03-23
ES2014060A6 (es) 1990-06-16
FI891438A7 (fi) 1989-09-24

Similar Documents

Publication Publication Date Title
FR2393055A1 (fr) Nouveaux agents d'acylation acides carboxyliques, leurs derives, compositions concentrees et lubrifiantes les contenant et procede pour leur preparation
HUT70536A (en) Arylsulfonamido-substituted hydroxamic acids, process for preparing them and pharmaceutical compositions containing them
CA2075876A1 (fr) Nouveaux derives d'arylethylamines, leurs procedes de preparation et lescompositions pharmaceutiques qui les contiennent
HU9403795D0 (en) Highly concentrated immunoglobulin preparation and method for its production
BE1002890A3 (fr) Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer.
EP0618259A3 (en) Thermoplastic elastomer composition, process for its preparation and molding composition from this thermoplastic elastomer.
FR2440371A1 (fr) Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
SE8901041D0 (sv) Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning
FR2714059B1 (fr) Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
BE1002428A3 (fr) Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation.
BE1002429A3 (fr) Compositions dietetiques et procede pour leur preparation.
FR2392068A1 (fr) Procede de production d'une charge particulaire enrobee pour polymeres organiques
FR2708609B1 (fr) Dérivés de méthylguanidine, leurs procédés de préparation ainsi que les compositions en contenant.
NZ242155A (en) 4-aminobutoxyphosphonic acid derivatives, their preparation using streptomyces platensis, and pharmaceutical compositions
DE3569122D1 (en) Membrane polysaccharides especially useful as medicines, and process for their preparation
BE901433A (fr) Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer.
FR2612526B1 (fr) Procede de preparation d'un additif suralcanise renfermant un derive du bore, l'additif ainsi obtenue et compositions lubrifiantes renfermant ledit additif
FR2642423B1 (fr) Procede de preparation d'alkyldiethanolamides gras purifies, les produits obtenus et leurs utilisations
FR2456474A1 (fr) Agent d'entretien pouvant etre pulverise a partir d'un conteneur, et procede pour l'entretien d'instruments medicaux, notamment de dentisterie avec un tel agent
FR2378054A1 (fr) Procede de preparation de polyurethanes
BE1001522A3 (fr) Compositions cosmetiques regenerant la peau et leur procede de preparation.
KR950014314A (ko) 하이드록실화되거나 산화된 지질 측쇄를 갖는 모에노마이신 분해 생성물 및 모에노마이신 동족체, 이들 화합물의 제조 방법 및 용도
DE69313634D1 (de) Elastosole sowie deren herstellung, verwendung und produkte
BE901959A (fr) Solution injectable, notamment pour le traitement de la cetose et son procede de preparation.
AU1462495A (en) Anti-wear additives and their use

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BIOREX KFT

Effective date: 19960331